Evidence map›Paper›PMID 38003726›Full record

ArticleInternational journal of molecular sciences2023

Role of the p38/AKT Pathway in the Promotion of Cell Proliferation by Serum Heat Inactivation.

Huijun Geng, Rongnuo Li, Dingping Feng, Yuanyuan Zhu, Lu Deng

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.4field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 2 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Huijun GengCollege of Animal Science and Technology, Northwest A&F University, Yangling, Xianyang 712100, China.
Rongnuo LiCollege of Animal Science and Technology, Northwest A&F University, Yangling, Xianyang 712100, China.
Dingping FengCollege of Animal Science and Technology, Northwest A&F University, Yangling, Xianyang 712100, China.
Yuanyuan ZhuCollege of Animal Science and Technology, Northwest A&F University, Yangling, Xianyang 712100, China.
Lu DengCollege of Animal Science and Technology, Northwest A&F University, Yangling, Xianyang 712100, China.
Northwest A&F University · CN

Funding

Guangdong Basic and Applied Basic Research Foundation 2021A1515220036National Natural Science Foundation of China 32070782
6 · The paper itself

Abstract

Serum is a common biomaterial in cell culture that provides nutrients and essential growth factors for cell growth. Serum heat inactivation is a common treatment method whose main purpose is to remove complement factors and viruses. As serum contains many heat-labile factors, heat inactivation may affect cell proliferation, migration, differentiation, and other functions. However, the specific mechanism of its effect on cell function has not been studied. Thus, we investigate the exact effects of heat-inactivated FBS on the viability of various cells and explore the possible molecular mechanisms. We treated HCT116, HT-29, and HepG2 cell lines with heat-inactivated (56 °C for 30 min) medium, DMEM, or fetal bovine serum (FBS) for different times (0, 10, 15, 30, 60, or 90 min); we found that heat-inactivated FBS significantly promoted the viability of these cells, whereas DMEM did not have this effect. Moreover, heat-inactivated FBS stimulated cells to produce a small amount of ROS and activated intracellular signaling pathways, mainly the p38/AKT signaling pathway. These results indicate that heat-inactivated FBS may regulate the p38/AKT signaling pathway by promoting the production of appropriate amounts of ROS, thereby regulating cell viability.

Indexed as

Hot TemperatureProto-Oncogene Proteins c-aktCell ProliferationReactive Oxygen SpeciesSignal TransductionProto-Oncogene Proteins c-aktReactive Oxygen Speciescell proliferationheat inactivationp38/AKT pathwayROSserum

Identifiers

PMID38003726
PMCPMC10671805
OpenAlexW4388834495

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.